THURSDAY, Feb. 3, 2022 (HealthDay News) — Alan Holman didn’t stop exercising when told he had cancer, and he’s glad of it, now that U.K. researchers say moderate exercise may improve chemotherapy outcomes in esophageal cancer patients. Holman, 70, was diagnosed with esophageal cancer in December 2016, shortly after retiringContinue Reading
WEDNESDAY, Feb. 2, 2022 (HealthDay News) — Pfizer Inc. announced Tuesday that it has asked the U.S. Food and Drug Administration to authorize its two-dose COVID vaccine for emergency use in children under 5 while it continues to research the power of a third shot in these youngest Americans. IfContinue Reading
WEDNESDAY, Feb. 2, 2022 (HealthDay News) — As the number of U.S. children with COVID-19 continues to surge, there are a number of things parents should know, a pediatric infectious disease expert says. “What used to be the average number of children with COVID for the whole hospital is nowContinue Reading
TUESDAY, Feb. 1, 2022 (HealthDay News) — Vaccinations have been given to the first volunteers in a Phase 1 trial of Moderna’s experimental HIV vaccine, the company has announced. The vaccine uses mRNA technology — similar to that utilized in breakthrough COVID vaccines — to deliver HIV-specific antigens that couldContinue Reading
TUESDAY, Feb. 1, 2022 (HealthDay News) — You smoked a joint an hour and a half ago. Now it’s worn off enough that you feel fine to get behind the wheel. But you’re fooling yourself, a new study says. You’re likely about to drive under the influence of weed, endangeringContinue Reading
TUESDAY, Feb. 1, 2022 (HealthDay News) — Pfizer Inc. plans to ask the U.S. Food and Drug Administration as soon as Tuesday to authorize its COVID vaccine for emergency use in children aged 6 months to 4 years old. If approved, the two-shot regimen would become the first approved forContinue Reading
MONDAY, Jan. 31, 2022 (HealthDay News) — Moderna’s COVID-19 vaccine has received full approval for use in people 18 and older, the U.S. Food and Drug Administration announced Monday. The vaccine, which has been available for that age group under emergency use authorization (EUA), will be marketed as Spikevax. It’sContinue Reading
MONDAY, Jan. 31, 2022 (HealthDay News) — The so-called “stealth” variant of Omicron isn’t likely to cause another devastating wave of COVID-19, experts say. The new version of the variant, called BA.2, doesn’t appear to cause more severe disease and vaccines are just as effective against it as against theContinue Reading
SUNDAY, Jan. 30, 2022 (HealthDay News) — Tempted to take your workout into the great outdoors? Be aware that there are both benefits and risks to exercising outdoors during the winter. “There’s actually some advantages to working out in cold weather – with no heat and humidity to deal withContinue Reading
FRIDAY, Jan. 28, 2022 (HealthDay News) — COVID-19 vaccines activate long-lasting immune system T-cells that target coronavirus variants of concern, including Delta and Omicron, new research shows. The research team at the La Jolla Institute for Immunology in California studied adults who were fully vaccinated with the Pfizer, Moderna, JohnsonContinue Reading